Literature DB >> 28506799

Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopy.

E Klang1, U Kopylov2, R Eliakim2, N Rozendorn3, D Yablecovitch2, A Lahat2, S Ben-Horin2, M M Amitai1.   

Abstract

AIM: To investigate the role of restricted diffusion in quiescent Crohn's disease (CD) patients and its association with inflammatory biomarkers and endoscopic disease.
MATERIAL AND METHODS: Fifty-two quiescent CD patients prospectively underwent magnetic resonance enterography (MRE) and video capsule endoscopy (VCE) and were tested for the inflammatory biomarkers, faecal calprotectin (FCP) and C-reactive protein (CRP). Restricted diffusion in the distal ileum was qualitatively (absence/presence) and quantitatively (apparent diffusion coefficient [ADC]) assessed by two readers. The VCE-based Lewis score was calculated for the distal ileum. Restricted diffusion sensitivity and specificity for VCE ulcerations were assessed for patients with elevated (>100 μg/g) or normal (<100 μg/g) FCP. Receiver operating characteristic (ROC) curve was used to assess the ability of ADC to identify patients with concurrent VCE ulceration and elevated FCP.
RESULTS: The sensitivity and specificity of restricted diffusion for patients with VCE ulceration were higher in patients with elevated FCP (reader 1: 71.4%, 80%, reader 2: 76.2%, 100%, respectively) compared to patients with normal FCP (reader 1: 46.2%, 61.5%; reader 2: 15.4%, 76.9%, respectively). The ADC had a high diagnostic accuracy for identifying patients that had concurrent VCE ulceration and elevated FCP (reader 1: AUC=0.819, reader 2: AUC=0.832).
CONCLUSION: In quiescent CD patients, the presence of restricted diffusion is suggestive of an active inflammation, associated with elevated FCP. Thus, DWI may serve as a clinical tool in the follow-up of these patients, implying subclinical inflammatory flares.
Copyright © 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28506799     DOI: 10.1016/j.crad.2017.04.006

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  7 in total

1.  Ability of DWI to characterize bowel fibrosis depends on the degree of bowel inflammation.

Authors:  Xue-Hua Li; Ren Mao; Si-Yun Huang; Zhuang-Nian Fang; Bao-Lan Lu; Jin-Jiang Lin; Shan-Shan Xiong; Min-Hu Chen; Zi-Ping Li; Can-Hui Sun; Shi-Ting Feng
Journal:  Eur Radiol       Date:  2019-01-11       Impact factor: 5.315

Review 2.  Advanced imaging techniques for small bowel Crohn's disease: what does the future hold?

Authors:  Inês Pita; Fernando Magro
Journal:  Therap Adv Gastroenterol       Date:  2018-02-12       Impact factor: 4.409

Review 3.  A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Authors:  Noa Rozendorn; Marianne Michal Amitai; Rami Abraham Eliakim; Uri Kopylov; Eyal Klang
Journal:  Therap Adv Gastroenterol       Date:  2018-04-13       Impact factor: 4.409

4.  Magnetic resonance imaging and Crohn's disease endoscopic index of severity: Correlations and concordance.

Authors:  Nai-Yi Zhu; Xue-Song Zhao; Fei Miao
Journal:  World J Gastroenterol       Date:  2018-06-07       Impact factor: 5.742

5.  Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease.

Authors:  Nadia Mazen Hijaz; Thomas Mario Attard; Jennifer Marie Colombo; Neil Joseph Mardis; Craig Alan Friesen
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

6.  Evaluating inflammatory activity in Crohn's disease by cross-sectional imaging techniques.

Authors:  Bruno Cunha Fialho Cantarelli; Rafael Santiago de Oliveira; Aldo Maurici Araújo Alves; Bruno Jucá Ribeiro; Fernanda Velloni; Giuseppe D'Ippolito
Journal:  Radiol Bras       Date:  2020 Jan-Feb

7.  Diagnostic significance of mesenteric lymph node involvement in proximal small bowel Crohn's disease.

Authors:  Giovanni Maconi; Vera Sorin; Uri Kopylov; Oranit Barzilay; Francesca Ferretti; Silvia Innamorati; Massimo Tonolini; Rami Eliakim; Michal Marianne Amitai
Journal:  Therap Adv Gastroenterol       Date:  2022-08-22       Impact factor: 4.802

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.